Neoadjuvant chemotherapy for breast cancer determined by chemosensitivity assay achieves better tumor response

Biomedicine and Pharmacotherapy

Volumn 61, Issue 9 SPEC. ISS., 2007, Pages 562-565

  Lau, Gregory I S K ^a   Loo, Wings T Y ^a   Chow, Louis W C ^a  

^a UNIMED Medical Institute   (Hong Kong)

Author keywords

ATP bioluminescence; Chemosensitivity assay; Clinical trial; Evidence based medicine; Solid tumor

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; MITOMYCIN C; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BIOASSAY; BIOLUMINESCENCE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER SURGERY; CELL ACTIVITY; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MULTIPLE CYCLE TREATMENT; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SOLID TUMOR; TREATMENT RESPONSE; TUMOR CELL; TUMOR VOLUME;

EID: 35248898436     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2007.08.013     Document Type: Article

References (15)

1. Parkin D.M., Whelan S.L., Ferlay J., and Storm H. Cancer incidence in five continents vol. I-VIII (2005), Cancer Base, IARC, Lyon No. 7
2. Althuis M.D., Dozier J.M., Anderson W.F., Devesa S.S., and Brinton L.A. Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 34 (2005) 405-412
3. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics. CA Cancer J Clin 2005 55 (2002) 74-108
4. Undevia S.D., Gomez-Abuin G., and Ratain M.J. Pharmacokinetic variability of anticancer agents. Nat Rev Cancer 5 (2005) 447-458
5. de Jonge M.E., Huitema A.D., Schellens J.H., Rodenhuis S., and Beijnen J.H. Individualised cancer chemotherapy: strategies and performance of prospective studies on therapeutic drug monitoring with dose adaptation: a review. Clin Pharmacokinet 44 (2005) 147-173
6. Kurbacher C.M., Grecu O.M., Stier U., Gilster T.J., Janat M.M., Untch M., et al. ATP chemosensitivity testing in ovarian and breast cancer: early clinical trials. Recent Results Cancer Res 161 (2003) 221-230
7. Mollgard L., Tidefelt U., Sundman-Engberg B., Lofgren C., and Paul C. In vitro chemosensitivity testing in acute non lymphocytic leukemia using the bioluminescence ATP assay. Leuk Res 24 (2000) 445-452
8. Furukawa T., Kubota T., Tanino H., Oura S., Yuasa S., Murate H., et al. Chemosensitivity of breast cancer lymph node metastasis compared to the primary tumor from individual patients tested in the histoculture drug response assay. Anticancer Res 20 (2000) 3657-3658
9. Tanigawa N., Kitaoka A., Yamakawa M., Tanisaka K., and Kobayashi H. In vitro chemosensitivity testing of human tumors by collagen gel droplet culture and image analysis. Anticancer Res 16 (1996) 1925-1930
10. Cree I.A., Pazzagli M., Mini E., Mazzei T., Hunter E.M., Sutherland L.A., et al. Methotrexate chemosensitivity by ATP luminescence in human leukemia cell lines and in breast cancer primary cultures: comparison of the TCA-100 assay with a clonogenic assay. Anticancer Drugs 6 (1995) 398-404
11. Rhedin A.S., Tidefelt U., Jonsson K., Lundin A., and Paul C. Comparison of a bioluminescence assay with differential staining cytotoxicity for cytostatic drug testing in vitro in human leukemic cells. Leuk Res 17 (1993) 271-276
12. Bellamy W.T. Prediction of response to drug therapy of cancer. A review of in vitro assays. Drugs 44 (1992) 690-708
13. Nguyen H.N., Sevin B.U., Averette H.E., Perras J., Donato D., and Penalver M. The use of ATP bioluminescence assays in selecting a drug screen panel for chemosensitivity testing of uterine cancer cell lines. Gynecol Oncol 45 (1992) 185-191
14. Kretschmar M., Nichterlein T., Kuntz P., and Hof H. Rapid detection of susceptibility to fluconazole in Candida species by a bioluminescence assay of intracellular ATP. Diagn Microbiol Infect Dis 25 (1996) 117-121
15. Bear H.D., Anderson S., Brown A., Smith R., Mamounas E.P., Fisher B., et al. The effect on tumor response of adding sequential preoperative paclitaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 21 (2003) 4165-4174